Package 41226-609-05

Brand: naproxen sodium

Generic: naproxen sodium
NDC Package

Package Facts

Identity

Package NDC 41226-609-05
Digits Only 4122660905
Product NDC 41226-609
Product ID 41226-609_c3d6166b-be1b-328a-e053-2a95a90af589
Description

1 BOTTLE in 1 CARTON (41226-609-05) / 50 TABLET, COATED in 1 BOTTLE

Marketing

Marketing Status
Marketed Since 2021-06-12
Brand naproxen sodium
Generic naproxen sodium
Sample Package No

Linked Drug Pages (1)

NAPROXEN SODIUM ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "c3d6166b-be1b-328a-e053-2a95a90af589", "openfda": {"unii": ["9TN87S3A3C"], "rxcui": ["849574"], "spl_set_id": ["bc185bf2-bc2c-f439-e053-2995a90a93d0"], "manufacturer_name": ["Kroger Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (41226-609-05)  / 50 TABLET, COATED in 1 BOTTLE", "package_ndc": "41226-609-05", "marketing_start_date": "20210612"}], "brand_name": "NAPROXEN SODIUM", "product_id": "41226-609_c3d6166b-be1b-328a-e053-2a95a90af589", "dosage_form": "TABLET, COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "41226-609", "generic_name": "NAPROXEN SODIUM", "labeler_name": "Kroger Company", "product_type": "HUMAN OTC DRUG", "brand_name_base": "NAPROXEN SODIUM", "active_ingredients": [{"name": "NAPROXEN SODIUM", "strength": "220 mg/1"}], "application_number": "ANDA090545", "marketing_category": "ANDA", "marketing_start_date": "20210612", "listing_expiration_date": "20261231"}